Posts Tagged: "Patent Litigation"

The United States District Court for the District of Delaware handed Allergan, Inc. (NYSE:AGN) a victory last week in its patent infringement lawsuit brought against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd., Apotex, Inc. and Apotex Corp. The defendants had been seeking permission to market generic versions of Allergan’s drugs ALPHAGAN® P, which is indicated for the lowering of intraocular…

I hardly keep it a secret that the Practising Law Institute is a sponsor of IPWatchdog.com, although not necessarily the views expressed herein, which are mine alone.  Occasionally I engage in some outright promotion activities, and stealing a good idea from the National Public Radio duo — Click & Clack — I sometimes refer to it as coming from the…

The appeal in Lucent Technologies, Inc. v. Gateway, Inc. from the Southern District of California was considered in many quarters as the potentially seminal case on how to calculate damages based on a reasonable royalty using the Georgia-Pacific factors, especially the “entire market value” rule (aka factor 13). That Microsoft and others were currently on the hook to Lucent Technologies…

Three weeks ago, TechRadium, Inc., a Texas Corporation with its principal place of business in Sugar Land, Texas, sued Twitter, Inc., a Delaware corporation with its principal place of business in San Francisco, California, alleging the infringement of US Patent No. 7,130,389, issued on October 31, 2006, and US Patent No. 7,496,183, issued on February 24, 2009, and US Patent…

Earlier today, Judge Garrett Brown of the United States Federal District Court for the District of New Jersey, issued an Order and Findings of Fact and Conclusions of Law in the dispute between between Merck and Teva Pharmaceuticals.  Judge Brown found that the patent in question, US Patent No. 5,565,473, was valid and enforceable, and that the Teva’s Abbreviated New…

Last week I gave an interview to Mark McCarty at Medical Device Daily, which published on Monday, August 17, 2009.  We had a good conversation for almost two hours about all kinds of patent topics.  Sometimes when you talk to reporters you never really know whether they are following what you are saying, whether they will wait for that one…

Yesterday, Leonard Davis, a United States District Court Judge in the Eastern District of Texas, ordered Microsoft Corporation to stop selling Word, an order that becomes effective in 59 days (i.e., 60 days from yesterday).  The permanent injunction issued after the conclusion of a patent infringement lawsuit brought by i4i Limited Partnership, a litigation where Microsoft was found to infringe…

Patent Bar Review September 22-26, 2009, New York City In clear, concise, right-to-the-point language, this information-packed course leads you through the intricacies – and around the traps – of the Patent Bar Exam. You’ll get the hard facts, test-taking tips, sample questions and answers, and intense practice exams that mirror what you’re going to face when you sit down to…

In a decision that is simply painful to read, the United States Court of Appeals for the Federal Circuit yesterday decided in Autogenomics v. Oxford Gene Technology that a foreign patent owner cannot be made a defendant to a lawsuit seeking a declaratory judgment of invalidity, unenforceability and noninfringement.  According to the majority opinion, Oxford is a British biotechnology company…

The ACLU should be sanctioned for its frivolous lawsuit challenging gene patents, which was filed Tuesday in the United States Federal District Court for the Southern District of New York.  This lawsuit is nothing more than grandstanding, it presents frivolous arguments and outright lies.  The ACLU would have you believe that the patents cover naturally occurring genes, which is simply…

The PLI Patent Litigation treatise edited by Laurence Pretty has just been updated and includes updates of five chapters, providing you with the information and strategies you need to litigate patent cases successfully. Contributors for this release are John M. Skenyon (chapter 2), Andrei Iancu, Lisa Partain, and Kenneth Weatherwax (chapter 3), Brian E. Ferguson (chapter 4), Patricia Martone (chapter…

According to an article on GovernmentExecutive.com, an announcement regarding appointment of an Undersecretary of Commerce for Intellectual Property (a.k.a., Director of the USPTO) could come within the next week or two.  This news of a new leader on the horizon seems to be quite pleasing to Robert Budens, the President of the Patent Office Professional Association, which is an independent…

The program this morning ran a bit long, and we are behind, but there is such great information being covered here at the Improving Patent Adjudication Through ADR and Federal Court Reform symposium being sponsored by the Thomas Jefferson School of Law.  One particular presentation that was exceptional (and there have been many) is the presentation by Judge James F.…

I am writing from San Diego, California this morning.  I am sitting in an auditorium at Qualcomm, where the Thomas Jefferson School of Law is holding a symposium titled Improving Patent Adjudication Through ADR and Federal Court Reform.  This is a special event for me personally because not only am I a speaker, but I also inspired the research project…

On Tuesday, March 10, 2009, Dr. Reddy’s Laboratories (NYSE:RDY) prevailed in a patent dispute with Astra Zeneca, receiving a summary judgment victory in the ongoing dispute before the United States Federal District Court for the Southern District of New York.  U.S. District Court Judge Colleen McMahon ruled that the Omeprazole Magnesium OTC Abbreviated New Drug Application (ANDA) filed by Dr. Reddy’s does not…